Brown, Lisle/Cummings, Inc. Novartis Ag Transaction History
Brown, Lisle/Cummings, Inc.
- $307 Billion
- Q2 2024
A detailed history of Brown, Lisle/Cummings, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 1,908 shares of NVS stock, worth $202,496. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,908
Previous 888
114.86%
Holding current value
$202,496
Previous $85.9 Million
136.48%
% of portfolio
0.07%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding NVS
# of Institutions
1,359Shares Held
140MCall Options Held
1.15MPut Options Held
866K-
Primecap Management CO Pasadena, CA12.4MShares$1.32 Billion0.91% of portfolio
-
Dodge & Cox San Francisco, CA12.4MShares$1.31 Billion0.73% of portfolio
-
Morgan Stanley New York, NY7.26MShares$770 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX6.02MShares$639 Million0.16% of portfolio
-
Loomis Sayles & CO L P5.92MShares$628 Million0.81% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $228B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...